Cheng Zhou

No. 801, Heqing Road
Minhang, 200240, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinoma.

PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinoma.

Journal: Discover oncology

Published: May 26, 2025

Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression.

Elevated VRK1 levels after androgen deprivation therapy promote prostate cancer progression by upregulating YAP1 expression.

Journal: Journal of cancer research and clinical oncology

Published: February 08, 2025

FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion.

FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion.

Journal: Cell & bioscience

Published: July 12, 2024

Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis.

Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis.

Journal: Cancer medicine

Published: May 15, 2024

Acalabrutinib alleviates metabolic dysfunction-associated steatotic liver disease by regulating bile acid metabolism.

Acalabrutinib alleviates metabolic dysfunction-associated steatotic liver disease by regulating bile acid metabolism.

Journal: The international journal of biochemistry & cell biology

Published: April 23, 2024

Interleukin 35 promotes progression of hepatocellular carcinoma by recruiting neutrophils.

Interleukin 35 promotes progression of hepatocellular carcinoma by recruiting neutrophils.

Journal: Translational oncology

Published: April 03, 2024

Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis.

Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis.

Journal: Journal of cancer research and clinical oncology

Published: March 10, 2024

Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism.

Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism.

Journal: Biomolecules

Published: January 16, 2024

USP54 is a potential therapeutic target in castration-resistant prostate cancer.

USP54 is a potential therapeutic target in castration-resistant prostate cancer.

Journal: BMC urology

Published: November 20, 2023

Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infections.

Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infections.

Journal: World journal of hepatology

Published: August 28, 2023

Aberrant dentato-rubro-thalamic pathway in action tremor but not rest tremor: A multi-modality magnetic resonance imaging study.

Aberrant dentato-rubro-thalamic pathway in action tremor but not rest tremor: A multi-modality magnetic resonance imaging study.

Journal: CNS neuroscience & therapeutics

Published: March 08, 2023

Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma.

Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: December 18, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026